These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9532835)

  • 1. [Inflammatory response to acute Trypanosoma cruzi infection].
    Cardoni RL
    Medicina (B Aires); 1997; 57(2):227-34. PubMed ID: 9532835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of cytokines in resistance and pathology in Trypanosoma cruzi infection].
    Laucella SA; Rottenberg ME; de Titto EH
    Rev Argent Microbiol; 1996; 28(2):99-109. PubMed ID: 8768488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection.
    Abel LC; Rizzo LV; Ianni B; Albuquerque F; Bacal F; Carrara D; Bocchi EA; Teixeira HC; Mady C; Kalil J; Cunha-Neto E
    J Autoimmun; 2001 Aug; 17(1):99-107. PubMed ID: 11488642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
    Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C
    Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of chronic cardiomyopathy in canine Chagas disease correlates with high IFN-gamma, TNF-alpha, and low IL-10 production during the acute infection phase.
    Guedes PM; Veloso VM; Afonso LC; Caliari MV; Carneiro CM; Diniz LF; Marques-da-Silva EA; Caldas IS; Do Valle Matta MA; Souza SM; Lana M; Chiari E; Galvão LM; Bahia MT
    Vet Immunol Immunopathol; 2009 Jul; 130(1-2):43-52. PubMed ID: 19211152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of nitric oxide (NO) and TNF-alpha in the oxidative stress associated with anemia in experimental Trypanosoma cruzi infection.
    Malvezi AD; Cecchini R; de Souza F; Tadokoro CE; Rizzo LV; Pinge-Filho P
    FEMS Immunol Med Microbiol; 2004 May; 41(1):69-77. PubMed ID: 15094169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin enhances pro-inflammatory cytokine levels and protects against Chagas disease.
    Santello FH; Frare EO; Caetano LC; AlonsoToldo MP; do Prado JC
    J Pineal Res; 2008 Aug; 45(1):79-85. PubMed ID: 18284549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanosoma cruzi: roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance.
    Nickell SP; Sharma D
    Exp Parasitol; 2000 Apr; 94(4):207-16. PubMed ID: 10831388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma cruzi: populations bearing opposite virulence induce differential expansion of circulating CD3+CD4-CD8- T cells and cytokine serum levels in young and adult rats.
    Nagib PR; Dutra WO; Chiari E; Machado CR
    Exp Parasitol; 2007 Aug; 116(4):366-74. PubMed ID: 17399706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage activity, IL-6 levels, antibody response and heart histology in rats undergoing an attenuated Trypanosoma cruzi acute infection upon treatment with recombinant interferon gamma.
    Revelli S; Didoli G; Roggero E; Moreno H; Bernabo J; Wietzerbin J; Bottasso O
    Cytokines Cell Mol Ther; 1998 Sep; 4(3):153-9. PubMed ID: 9825840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the cellular immune response in patients with the digestive and indeterminate forms of Chagas' disease.
    Ribeiro BM; Crema E; Rodrigues V
    Hum Immunol; 2008 Aug; 69(8):484-9. PubMed ID: 18582517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cells modulate T cells so as to favour T helper type 1 and CD8+ T-cell responses in the acute phase of Trypanosoma cruzi infection.
    Cardillo F; Postol E; Nihei J; Aroeira LS; Nomizo A; Mengel J
    Immunology; 2007 Dec; 122(4):584-95. PubMed ID: 17635611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of expression of inflammatory mediators in skeletal muscles from mice acutely infected with the RA strain of Trypanosoma cruzi.
    Cutrullis RA; Postan M; Petray PB; Corral RS
    Pathobiology; 2009; 76(4):170-80. PubMed ID: 19571606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspase inhibition reduces lymphocyte apoptosis and improves host immune responses to Trypanosoma cruzi infection.
    Silva EM; Guillermo LV; Ribeiro-Gomes FL; De Meis J; Nunes MP; Senra JF; Soares MB; DosReis GA; Lopes MF
    Eur J Immunol; 2007 Mar; 37(3):738-46. PubMed ID: 17295391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmania sp: comparative study with Toxoplasma gondii and Trypanosoma cruzi in their ability to initialize IL-12 and IFN-gamma synthesis.
    Oliveira MA; Santiago HC; Lisboa CR; Ceravollo IP; Trinchieri G; Gazzinelli RT; Vieira LQ
    Exp Parasitol; 2000 Jun; 95(2):96-105. PubMed ID: 10910710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymocyte depletion during acute Trypanosoma cruzi infection in C57BL/6 mice is partly reverted by lipopolysaccharide pretreatment.
    Roggero E; Piazzon I; Nepomnaschy I; Perez A; Velikovsky A; Revelli S; Bottasso O
    FEMS Immunol Med Microbiol; 2004 Jun; 41(2):123-31. PubMed ID: 15145456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficient control of Trypanosoma cruzi infection in C57BL/6 mice is related to a delayed specific IgG response and increased macrophage production of pro-inflammatory cytokines.
    Pérez AR; Tamae-Kakazu M; Pascutti MF; Roggero E; Serra E; Revelli S; Bottasso O
    Life Sci; 2005 Sep; 77(16):1945-59. PubMed ID: 15916779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressive action of melatonin on the TH-2 immune response in rats infected with Trypanosoma cruzi.
    Santello FH; Frare EO; dos Santos CD; Caetano LC; Alonso Toldo MP; do Prado JC
    J Pineal Res; 2008 Oct; 45(3):291-6. PubMed ID: 18373553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benznidazole treatment during early-indeterminate Chagas' disease shifted the cytokine expression by innate and adaptive immunity cells toward a type 1-modulated immune profile.
    Sathler-Avelar R; Vitelli-Avelar DM; Massara RL; Borges JD; Lana M; Teixeira-Carvalho A; Dias JC; Elói-Santos SM; Martins-Filho OA
    Scand J Immunol; 2006 Nov; 64(5):554-63. PubMed ID: 17032249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.